ReviewTranslational breast cancer research : a journal focusing on translational research in breast cancer2022

A narrative review of the clinical development of CDK4/6 inhibitor abemaciclib in breast cancer.

Liu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.